FDA Says Medicis' (MRX) 510(k) Application to Market LIPOSONIX Does Not Provide Sufficient Data
Tweet Send to a Friend
According to a Form 8-K filing from Medicis (NYSE: MRX), the FDA has issued a letter to the company notifying ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
